Table 3 |
||||||
|
Effects of pulse high-volume haemofiltration on haemodynamic variables |
||||||
| Variables |
Pre-PHVHF |
Mid-PHVHF |
End-PHVHF |
6 hours after PHVHF |
12 hours after PHVHF |
P |
|
|
||||||
| Noradrenaline Dose (μg/min) |
48 (0–114) |
40 (0–97)* |
40 (0–93) |
40 (0–69)* |
33 (0–67)** |
0.001 |
| SBP (mmHg) |
124.32 ± 25.63 |
126.64 ± 22.10 |
133.00 ± 24.55 |
133.06 ± 23.88 |
133.16 ± 26.15 |
0.04 |
| MAP (mmHg) |
82.16 ± 18.31 |
85.02 ± 18.82 |
86.88 ± 17.56 |
87.76 ± 20.65 |
87.26 ± 22.05 |
NS |
| CI (l/min per m2) |
3.4 ± 1.1 |
3.4 ± 1.2 |
3.5 ± 1.0 |
3.5 ± 1.1 |
3.5 ± 1.2 |
NS |
| HR (beats/min) |
97.28 ± 25.53 |
99.62 ± 22.94 |
100.06 ± 21.79 |
99.94 ± 20.71 |
95.62 ± 20.66 |
0.04 |
| Temperature (°C) |
36.7 ± 1.0 |
36.8 ± 0.8 |
36.8 ± 0.8 |
36.9 ± 0.8 |
36.7 ± 0.9 |
NS |
| PaO2/FiO2 |
230.9 ± 109.1 |
232.8 ± 104.4 |
243.0 ± 105.6 |
230.2 ± 109.9 |
234.6 ± 106.4 |
NS |
|
|
||||||
|
Normally distributed values are reported as mean ± standard deviation, and the statistical test used was analysis of variance for repeated measurements. Non-normally distributed values are reported as median (25th to 75th percentile), and P value was determined using Friedman's two-way analysis of varience with post-hoc Wilcoxon signed rank test. *P < 0.05, **P < 0.01 versus baseline. HR, heart rate; CI, cardiac index; MAP, mean arterial pressure; PaO2/FiO2, arterial oxygen tension/fractional inspired oxygen; PHVHF, pulse high-volume haemofiltration; SBP, systolic blood pressure. |
||||||
|
Ratanarat et al. Critical Care 2005 9:R294 doi:10.1186/cc3529 |
||||||
